202 related articles for article (PubMed ID: 20521030)
1. Effects of baclofen and mirtazapine on a laboratory model of marijuana withdrawal and relapse.
Haney M; Hart CL; Vosburg SK; Comer SD; Reed SC; Cooper ZD; Foltin RW
Psychopharmacology (Berl); 2010 Aug; 211(2):233-44. PubMed ID: 20521030
[TBL] [Abstract][Full Text] [Related]
2. Effects of THC and lofexidine in a human laboratory model of marijuana withdrawal and relapse.
Haney M; Hart CL; Vosburg SK; Comer SD; Reed SC; Foltin RW
Psychopharmacology (Berl); 2008 Mar; 197(1):157-68. PubMed ID: 18161012
[TBL] [Abstract][Full Text] [Related]
3. Marijuana withdrawal in humans: effects of oral THC or divalproex.
Haney M; Hart CL; Vosburg SK; Nasser J; Bennett A; Zubaran C; Foltin RW
Neuropsychopharmacology; 2004 Jan; 29(1):158-70. PubMed ID: 14560320
[TBL] [Abstract][Full Text] [Related]
4. A human laboratory study investigating the effects of quetiapine on marijuana withdrawal and relapse in daily marijuana smokers.
Cooper ZD; Foltin RW; Hart CL; Vosburg SK; Comer SD; Haney M
Addict Biol; 2013 Nov; 18(6):993-1002. PubMed ID: 22741619
[TBL] [Abstract][Full Text] [Related]
5. Nabilone decreases marijuana withdrawal and a laboratory measure of marijuana relapse.
Haney M; Cooper ZD; Bedi G; Vosburg SK; Comer SD; Foltin RW
Neuropsychopharmacology; 2013 Jul; 38(8):1557-65. PubMed ID: 23443718
[TBL] [Abstract][Full Text] [Related]
6. Effects of zolpidem alone and in combination with nabilone on cannabis withdrawal and a laboratory model of relapse in cannabis users.
Herrmann ES; Cooper ZD; Bedi G; Ramesh D; Reed SC; Comer SD; Foltin RW; Haney M
Psychopharmacology (Berl); 2016 Jul; 233(13):2469-78. PubMed ID: 27085870
[TBL] [Abstract][Full Text] [Related]
7. Nefazodone decreases anxiety during marijuana withdrawal in humans.
Haney M; Hart CL; Ward AS; Foltin RW
Psychopharmacology (Berl); 2003 Jan; 165(2):157-65. PubMed ID: 12439626
[TBL] [Abstract][Full Text] [Related]
8. Bupropion SR worsens mood during marijuana withdrawal in humans.
Haney M; Ward AS; Comer SD; Hart CL; Foltin RW; Fischman MW
Psychopharmacology (Berl); 2001 May; 155(2):171-9. PubMed ID: 11401006
[TBL] [Abstract][Full Text] [Related]
9. Predictors of marijuana relapse in the human laboratory: robust impact of tobacco cigarette smoking status.
Haney M; Bedi G; Cooper ZD; Glass A; Vosburg SK; Comer SD; Foltin RW
Biol Psychiatry; 2013 Feb; 73(3):242-8. PubMed ID: 22939992
[TBL] [Abstract][Full Text] [Related]
10. Guanfacine decreases symptoms of cannabis withdrawal in daily cannabis smokers.
Haney M; Cooper ZD; Bedi G; Herrmann E; Comer SD; Reed SC; Foltin RW; Levin FR
Addict Biol; 2019 Jul; 24(4):707-716. PubMed ID: 29659126
[TBL] [Abstract][Full Text] [Related]
11. Effects of a single dose of baclofen on self-reported subjective effects and tobacco smoking.
Cousins MS; Stamat HM; de Wit H
Nicotine Tob Res; 2001 May; 3(2):123-9. PubMed ID: 11403726
[TBL] [Abstract][Full Text] [Related]
12. Effects of smoked marijuana in healthy and HIV + marijuana smokers.
Haney M
J Clin Pharmacol; 2002 Nov; 42(S1):34S-40S. PubMed ID: 12412834
[TBL] [Abstract][Full Text] [Related]
13. Abstinence symptoms following smoked marijuana in humans.
Haney M; Ward AS; Comer SD; Foltin RW; Fischman MW
Psychopharmacology (Berl); 1999 Feb; 141(4):395-404. PubMed ID: 10090647
[TBL] [Abstract][Full Text] [Related]
14. Subjective, cognitive and cardiovascular dose-effect profile of nabilone and dronabinol in marijuana smokers.
Bedi G; Cooper ZD; Haney M
Addict Biol; 2013 Sep; 18(5):872-81. PubMed ID: 22260337
[TBL] [Abstract][Full Text] [Related]
15. Varenicline and nabilone in tobacco and cannabis co-users: effects on tobacco abstinence, withdrawal and a laboratory model of cannabis relapse.
Herrmann ES; Cooper ZD; Bedi G; Ramesh D; Reed SC; Comer SD; Foltin RW; Haney M
Addict Biol; 2019 Jul; 24(4):765-776. PubMed ID: 30378231
[TBL] [Abstract][Full Text] [Related]
16. Impact of cyclooxygenase-2 inhibition on cannabis withdrawal and circulating endocannabinoids in daily cannabis smokers.
Haney M; Bedi G; Cooper ZD; Herrmann ES; Reed SC; Foltin RW; Kingsley PJ; Marnett LJ; Patel S
Addict Biol; 2022 Jul; 27(4):e13183. PubMed ID: 35754107
[TBL] [Abstract][Full Text] [Related]
17. A placebo-controlled trial of mirtazapine for the management of methamphetamine withdrawal.
Cruickshank CC; Montebello ME; Dyer KR; Quigley A; Blaszczyk J; Tomkins S; Shand D
Drug Alcohol Rev; 2008 May; 27(3):326-33. PubMed ID: 18368615
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and tolerability of high-dose dronabinol maintenance in HIV-positive marijuana smokers: a controlled laboratory study.
Bedi G; Foltin RW; Gunderson EW; Rabkin J; Hart CL; Comer SD; Vosburg SK; Haney M
Psychopharmacology (Berl); 2010 Dec; 212(4):675-86. PubMed ID: 20824270
[TBL] [Abstract][Full Text] [Related]
19. 5HT-2C agonist lorcaserin decreases cannabis self-administration in daily cannabis smokers.
Arout CA; Cooper ZD; Reed SC; Foltin RW; Comer SD; Levin FR; Haney M
Addict Biol; 2021 Jul; 26(4):e12993. PubMed ID: 33389797
[TBL] [Abstract][Full Text] [Related]
20. [Motivations for cannabis cessation, coping and adaptation strategies, and perceived benefits: impact on cannabis use relapse and abstinence].
Chauchard E; Septfons A; Chabrol H
Encephale; 2013 Dec; 39(6):385-92. PubMed ID: 23928064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]